Literature DB >> 21597888

Venous thromboembolism after surgery for benign prostatic hyperplasia.

David Bergqvist1.   

Abstract

A systematic review has been performed on venous thromboembolism after surgery for benign prostatic hyperplasia. The risk of deep vein thrombosis is two to four times higher after open surgery than after transurethral resection. The risk after the newer transurethral methods (laser, radiofrequency, heat) is not known. Specific studies on thromboprophylaxis are few and have limited numbers of patients. Nonetheless, thromboprophylaxis (heparin) reduces the frequency of postoperative deep vein thrombosis after open surgery. Studies on patients undergoing transurethral resection are lacking. Antifibrinolytic treatment to diminish bleeding does not seem to increase the risk of thrombosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21597888     DOI: 10.1007/s00268-011-1150-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  35 in total

1.  Dextran and the prevention of postoperative thromboembolic complications.

Authors:  U F Gruber
Journal:  Surg Clin North Am       Date:  1975-06       Impact factor: 2.741

2.  Postoperative venous thrombosis in benign prostatic disease. A study of 316 patients, using the 125I-fibrinogen uptake test.

Authors:  P O Hedlund
Journal:  Scand J Urol Nephrol       Date:  1975

3.  Do low molecular weight heparin and dextran increase the blood loss in transurethral resection of the prostate?

Authors:  H Hjertberg; J Olsson; T Ekström; B Lisander
Journal:  Br J Urol       Date:  1996-12

Review 4.  Fibrinogen uptake test for detection of deep vein thrombosis--a review of current practice.

Authors:  V V Kakkar
Journal:  Semin Nucl Med       Date:  1977-07       Impact factor: 4.446

5.  Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. II. A clinical study with the aid of intravenous phlebography.

Authors:  J Becker; S Borgström; G F Saltzman
Journal:  Acta Chir Scand       Date:  1970

6.  Prevention of postoperative deep-vein thrombosis by low-dose heparin in open prostatectomy.

Authors:  M Vandendris; M Kutnowski; B Futeral; X Gianakopoulos; M Kraytman; W Gregoir
Journal:  Urol Res       Date:  1980

Review 7.  Prophylaxis of postoperative thromboembolism with low molecular weight heparins.

Authors:  L N Jørgensen; P Wille-Jørgensen; O Hauch
Journal:  Br J Surg       Date:  1993-06       Impact factor: 6.939

8.  Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.

Authors:  M T Nurmohamed; F R Rosendaal; H R Büller; E Dekker; D W Hommes; J P Vandenbroucke; E Briët
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

9.  The incidence of deep vein thrombosis in prostatectomised patients following the administration of the fibrinolytic inhibitor, aminocaproic acid (EACA).

Authors:  J Sinclair; C D Forbes; C R Prentice; R Scott
Journal:  Urol Res       Date:  1976-11-10

10.  Minidose heparin in transurethral prostatectomy.

Authors:  B B Bejjani; D C Chen; N G Nolan; M Edson
Journal:  Urology       Date:  1983-09       Impact factor: 2.649

View more
  1 in total

1.  Transurethral resection versus holmium laser enucleation of the prostate: A prospective randomized trial comparing perioperative thrombin generation and fibrinolysis.

Authors:  Fuding Bai; Sheng Feng; Congcong Xu; Zhen Xu; Jijun Chen; Yichun Zheng
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.